Aquestive Therapeutics, Inc.
AQSTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Aquestive Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| CITIGROUP INC | 2026-03-31 | 41,907 | $174K | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 25,718 | $107K | SEC filing |
| Lineweaver Wealth Advisors, LLC | 2026-03-31 | 10,000 | $41.5K | SEC filing |
| VANGUARD FIDUCIARY TRUST CO | 2026-03-31 | 637,512 | $2.65M | SEC filing |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 47,783 | $198K | SEC filing |
| Bleakley Financial Group, LLC | 2026-03-31 | 135,767 | $563K | SEC filing |
| Wealthfront Advisers LLC | 2026-03-31 | 12,127 | $50.3K | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 44,407 | $184K | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 64,438 | $260K | SEC filing |
| Financial Engines Advisors L.L.C. | 2026-03-31 | 97,483 | $405K | SEC filing |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 2026-03-31 | 10,750 | $44.6K | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 27,300 | $113K | SEC filing |
| Sugar Maple Asset Management, LLC | 2026-03-31 | 58,060 | $241K | SEC filing |
| TRUST POINT INC. | 2026-03-31 | 31,048 | $129K | SEC filing |
| Parkwoods Wealth Partners, LLC | 2026-03-31 | 11,000 | $45.7K | SEC filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-03-31 | 290,060 | $1.2M | SEC filing |
| HBK Sorce Advisory LLC | 2026-03-31 | 42,547 | $184K | SEC filing |
| Pure Financial Advisors, LLC | 2026-03-31 | 21,950 | $91.1K | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 5,654 | $23.5K | SEC filing |
| Y-Intercept (Hong Kong) Ltd | 2026-03-31 | 26,992 | $112K | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Aquestive Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-10 · Barber Daniel: Larger than all 21 other insider sales of Common Stock on file. SEC filing
- 2025-10-15 · Jung Cassie: Larger than 19 of the 21 other insider sales of Common Stock on file. SEC filing
- 2025-09-26 · Barber Daniel: Larger than 20 of the 21 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2022-06-08–2022-06-14: 5 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2022-06-08–2022-06-08: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-23 | Krop Julie · Director | Common Stock | S — Open market or private sale | −25,000 | 5.02 | SEC filing |
| 2026-06-15 | Barber Daniel · President and CEO | Common Stock | S — Open market or private sale | −25,000 | 4.16 | SEC filing |
| 2026-05-15 | Barber Daniel · President and CEO | Common Stock | S — Open market or private sale | −8,257 | 4.29 | SEC filing |
| 2026-03-10 | Cioffi Melina · SVP, Regulatory Affairs | Common Stock | S — Open market or private sale | −25,311 | 4.17 | SEC filing |
| 2026-03-10 | Jung Cassie · Chief Operating Officer | Common Stock | S — Open market or private sale | −45,791 | 4.17 | SEC filing |
| 2026-03-10 | BRAENDER LORI J · Chief Legal Officer | Common Stock | S — Open market or private sale | −40,102 | 4.17 | SEC filing |
| 2026-03-10 | TOTH A ERNEST JR · Chief Financial Officer | Common Stock | S — Open market or private sale | −58,254 | 4.17 | SEC filing |
| 2026-03-10 | Boyd Peter E. · Chief People Officer | Common Stock | S — Open market or private sale | −29,814 | 4.17 | SEC filing |
Showing 8 of 19 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-23 | Krop Julie · Director | Non-Qualified Stock Option (right to buy) | M — Exercise or conversion of derivative security | −25,000 | SEC filing |
| 2026-06-23 | Krop Julie · Director | Common Stock | M — Exercise or conversion of derivative security | +25,000 | SEC filing |
| 2026-06-10 | BROWN GREGORY B · Director | Stock Option (Right to Purchase) | A — Grant, award, or other acquisition | +50,500 | SEC filing |
| 2026-06-10 | Krop Julie · Director | Stock Option (Right to Purchase) | A — Grant, award, or other acquisition | +50,500 | SEC filing |
| 2026-06-10 | MORRIS TIMOTHY E · Director | Stock Option (right to purchase) | A — Grant, award, or other acquisition | +50,500 | SEC filing |
| 2026-06-10 | Taglietti Marco · Director | Stock Option (Right to Purchase) | A — Grant, award, or other acquisition | +50,500 | SEC filing |
| 2026-06-10 | Jenkins Abigail L. · Director | Non-Qualified Stock Option (right to buy) | A — Grant, award, or other acquisition | −50,500 | SEC filing |
| 2026-06-10 | Cochran John · Director | Stock Option (Right to Purchase) | A — Grant, award, or other acquisition | +50,500 | SEC filing |
Showing 8 of 32 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2021-03-12 | Cochran John · Director | Common Stock | J — Other acquisition or disposition | +8,228 | SEC filing |
| 2021-03-12 | Cochran John · Director | Common Stock | J — Other acquisition or disposition | +11,544 | SEC filing |
| 2021-03-12 | BRATTON DOUGLAS K · 10% owner | Common Stock | J — Other acquisition or disposition | −40,404 | SEC filing |
| 2021-03-12 | Cochran John · Director | Common Stock | J — Other acquisition or disposition | +23,038 | SEC filing |
| 2021-03-12 | BRATTON DOUGLAS K · 10% owner | Common Stock | J — Other acquisition or disposition | −524,675 | SEC filing |
| 2021-03-12 | BRATTON DOUGLAS K · 10% owner | Common Stock | J — Other acquisition or disposition | −564,160 | SEC filing |
| 2021-03-12 | BRATTON DOUGLAS K · 10% owner | Common Stock | J — Other acquisition or disposition | −2,249,077 | SEC filing |
| 2021-03-12 | BRATTON DOUGLAS K · 10% owner | Common Stock | J — Other acquisition or disposition | +1,783,578 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.